Of the 107 patients in the trial, 61% no longer qualified for PTSD after three treatment sessions. This data does not stand alone either. In a study conducted by Michael Mithoefer, Mark Wagner, Ann Mithoefer, Lisa Jerome, and Rick Roblin, and published in the Journal of Psychopharmacology, MDMA-assisted therapy was found to be a successful treatment as well. 83% of the participants no longer qualified for PSTD after four months of treatment. This study also supports the claims that MDMA has medical
Of the 107 patients in the trial, 61% no longer qualified for PTSD after three treatment sessions. This data does not stand alone either. In a study conducted by Michael Mithoefer, Mark Wagner, Ann Mithoefer, Lisa Jerome, and Rick Roblin, and published in the Journal of Psychopharmacology, MDMA-assisted therapy was found to be a successful treatment as well. 83% of the participants no longer qualified for PSTD after four months of treatment. This study also supports the claims that MDMA has medical